Your browser doesn't support javascript.
loading
Loss of MAGEC3 Expression Is Associated with Prognosis in Advanced Ovarian Cancers.
Ellegate, James; Mastri, Michalis; Isenhart, Emily; Krolewski, John J; Chatta, Gurkamal; Kauffman, Eric; Moffitt, Melissa; Eng, Kevin H.
Affiliation
  • Ellegate J; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
  • Mastri M; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
  • Isenhart E; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
  • Krolewski JJ; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
  • Chatta G; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
  • Kauffman E; Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
  • Moffitt M; Department of Gynecologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
  • Eng KH; Department of Cancer Genetics and Genomics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Cancers (Basel) ; 14(3)2022 Jan 30.
Article in En | MEDLINE | ID: mdl-35158998
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Cancers (Basel) Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Cancers (Basel) Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza